Locations:
SearchAdvertisement
Collaborative approach may reduce distress caused by neuropsychiatric symptoms
Guidance on patient selection, safety surveillance, choosing among agents and more
Real-world claims data and tissue culture studies set the stage for randomized clinical testing
Recognizing this association aids risk assessment before starting novel immunotherapies
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Study suggests sex-specific pathways show potential for sex-specific therapeutic approaches
Novel research is comparing sleep measures to biomarkers of neurodegeneration
High plasma ApoA1 and TG/HDL-C ratio predict faster progression
New research explores the role of immune cell and blood-brain barrier changes
Open-source artificial intelligence technology uses human genetic data to find candidate drugs
Experts weigh in on the amyloid hypothesis and how to use lecanemab if approved
Advertisement
Advertisement